Fig. 4From: Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAgThe restricted cubic spline of the association between HBsAb level and the risk of treatment outcomes. The models were adjusted for age, gender, treatment protocol, baseline HBsAg, HBeAg, DNA, ALT, and AST. Curves showed HRs compared with the chosen reference HBsAb level of 0.30 log10IU/L (2 IU/L)Back to article page